Last update 20 Mar 2025

Rh immunoglobulin-VF

Overview

Basic Info

Drug Type
Immunoglobulin
Synonyms
Human Anti-D Rho Immunoglobulin (CSL Behring), RHESOGAM
Target
Immunoglobulin x Rh factor
Action
agonists, modulators
Mechanism
Immunoglobulin agonists, Rh factor modulators(Blood group Rh(D) polypeptide modulators)
Therapeutic Areas
Hemic and Lymphatic Diseases
Active Indication
Hematologic Diseases
Inactive Indication-
Originator Organization
CSL Behring LLCCSL Behring LLC
Active Organization
CSL Behring LLCCSL Behring LLCCSL Behring (Australia) Pty Ltd.CSL Behring (Australia) Pty Ltd.
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
Australia (22 Dec 2009),
Hematologic Diseases
Regulation-
Login to view timeline

Related

100 Clinical Results associated with Rh immunoglobulin-VF
Login to view more data
100 Translational Medicine associated with Rh immunoglobulin-VF
Login to view more data
100 Patents (Medical) associated with Rh immunoglobulin-VF
Login to view more data
3
Literatures (Medical) associated with Rh immunoglobulin-VF
01 Jan 1969Revue Française de Transfusion
Prévention de la maladie hémolytique néo-natale par l'immunoglobine anti-Rh̆o/D/ humaine
01 Dec 1958American Journal of Obstetrics and GynecologyQ1 · MEDICINE
The Effects of Orally Administered RH Hapten**Supported by a grant from Gerber Products Company, Fremont, Mich.
Q1 · MEDICINE
NITA
Rh immunoglobulin prophylaxis.
100 Deals associated with Rh immunoglobulin-VF
Login to view more data

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Hematologic Diseases
Australia
CSL Behring (Australia) Pty Ltd.CSL Behring (Australia) Pty Ltd.
22 Dec 2009
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free